Exposure to mycobacterium avium complex (MAC) infection happens because of contaminated water or soil. Learn who gets severe ...

The company said epetraborole is the first drug candidate with statistically favorable patient reported outcome-based improvement in a treatment-refractory Mycobacterium avium Complex population. AN2 ...

Mizuho Securities analyst Graig Suvannavejh has maintained their bullish stance on INSM stock, giving a Buy rating on November 5. Graig ...

Assetmark Inc. raised its holdings in Insmed Incorporated (NASDAQ:INSM – Free Report) by 12.9% in the 3rd quarter, according ...

The company has also laid off 39% of its staff as it discontinued the development of SPR720 for non-tuberculous mycobacterial ...

To date, over 190 species and 14 subspecies of NTM have been identified. Among them, the most common pathogenic NTM include the Mycobacterium avium complex and Mycobacterium abscessus complex. In ...

Van ECK Associates Corp bought a new position in Insmed Incorporated (NASDAQ:INSM – Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and ...

ABSTRACT: Background: Mycobacterium avium complex (MAC) infection case which involves bones and joints are rare scenarios. Here, we report a rare case of Penicillium marneffei (PM), lung infection and ...

A fourth of patients with Mycobacterium avium complex pulmonary disease (MAC-PD) whose pre- and on-treatment isolates were the same species had genetically distinct strains within the same species in ...

BioVersys taps into key expertise of the established RespiriNTM consortium members and will lead development of its candidates through preclinical and clinical studies BioVersys’ NTM candidates are ...